GA Good Bad header

The Frustrating: Rapid Atrophy Growth Despite Treatment

Show Description +

What do you do when a patient’s GA lesions continue to grow despite regular treatment? Sunir Garg, MD, shares a real-world case from his clinic in which a patient’s disease advanced significantly despite receiving treatment over a 2-year period. Dr. Garg and moderator Judy Kim, MD, and panelists Deepak Sambhara, MD, and Rishi Singh, MD, explore challenges to explaining the value proposition of treatment to patients, discuss inter-modality imaging disagreements in GA patients, and gameplan decision-making around halting treatment in some GA patients.

Posted: 6/19/2025

Up Next

The Frustrating: IRF and SRF in a GA Patient

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD

The Good: Functional Vision, Small GA Lesion, Early Treatment

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD

The Bad: Declining Vision in an Age Before Anti-Complement Therapy

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD

The Frustrating: Rapid Atrophy Growth Despite Treatment

What do you do when a patient’s GA lesions continue to grow despite regular treatment? Sunir Garg, MD, shares a real-world case from his clinic in which a patient’s disease advanced significantly despite receiving treatment over a 2-year period. Dr. Garg and moderator Judy Kim, MD, and panelists Deepak Sambhara, MD, and Rishi Singh, MD, explore challenges to explaining the value proposition of treatment to patients, discuss inter-modality imaging disagreements in GA patients, and gameplan decision-making around halting treatment in some GA patients.

Posted: 6/19/2025


Please log in to leave a comment.